Back to Search
Start Over
Can acetazolamide be used to treat diseases involving increased bone mineral density?
- Publication Year :
- 2016
- Publisher :
- International Research and Cooperation Association for Bio & Socio-Sciences Advancement, 2016.
-
Abstract
- Sclerosing bone dysplasias are a series of clinically and genetically heterogeneous diseases characterized by functional failure of the osteoclasts in bone resorption, leading to an excessive amount of bone mineral density (BMD) which could have serious clinical consequences. We treated three children affected with seriously high levels of BMD with acetazolamide, with the intention of inducing metabolic acidosis, thus increasing bone resorption and reducing BMD. All our patients tolerated and followed the treatment well and the clinical response was satisfactory in all cases.
- Subjects :
- 0301 basic medicine
Bone mineral
musculoskeletal diseases
medicine.medical_specialty
Pathology
Increased bone mineral density
business.industry
Functional failure
Bone Dysplasias
Metabolic acidosis
Case Report
General Medicine
medicine.disease
Bone resorption
03 medical and health sciences
030104 developmental biology
Endocrinology
Internal medicine
medicine
Acetazolamide
business
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....baac5439602433890281a15f7fd8d6ad